ECP
PRTK

Empyrean Capital Partners’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Empyrean Capital Partners’s Portfolio PRTK Stock Details PRTK Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-669,000
Closed -$12M – 72
2017
Q4 		$12M Hold
669,000
– – 0.54% 31
2017
Q3 		$16.8M Buy
+669,000
New +$16.8M 0.65% 28